Collegium Pharmaceutical Inc (COLL) stock news · $1.12B cap
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This COLL news page leads with what Collegium Pharmaceutical Inc filed — not a scraped headline mill.
No cached 8-K sentence for COLL yet. We will not pad this page with generic market recap.
Latest reported COLL revenue for 2026-06-30 was $199.9M. Net income was -$15.1M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. COLL currently screens at market cap $1.12B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the COLL stock page; for the tape open the quote page.
COLL stock news FAQ
What are COLL's latest revenue and net income?
Latest cached Collegium Pharmaceutical Inc (COLL) revenue for Jun 30, 2026 was $199.9M. Net income was -$15.1M. Statements: https://lician.com/financials/coll
How did COLL revenue change from the prior cached period?
Cached Collegium Pharmaceutical Inc (COLL) revenue was up 3.3% from $193.5M (Mar 31, 2026) to $199.9M (Jun 30, 2026). Statements: https://lician.com/financials/coll
What is COLL's market cap?
Collegium Pharmaceutical Inc (COLL) market cap is $1.12B on the latest cached fundamentals snapshot.
What kind of company is COLL?
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is COLL stock news listed?
Cached stock news for Collegium Pharmaceutical Inc (COLL) is listed at https://lician.com/news/coll. Filings: https://lician.com/sec/coll
Not investment advice.